Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle
Moumoujus

HUMAN PLASMA.

Valuable / SKIN CONDITIONING

Human Plasma, predominantly utilized in its Platelet-Rich Plasma (PRP) form, is a sophisticated bioactive ingredient recognized for its profound capacity to stimulate the skin's intrinsic regenerative and healing mechanisms. Abundant in essential growth factors, it precisely targets cellular renewal, significantly enhancing collagen and elastin synthesis for superior skin architecture and vitality.

Summary

Skin-identical ingredient Cell-communicating ingredient Antioxidant Collagen booster Elastin booster Skin regeneration Anti-aging Texture improvement Pore minimization Scar reduction UV damage protection Wound healing

Science

Mechanism of Action

Platelet-Rich Plasma (PRP), derived from human plasma, exerts its dermatological benefits by releasing a concentrated spectrum of endogenous growth factors, including Platelet-Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor-beta (TGFβ), and Epidermal Growth Factor (EGF). These potent signaling molecules orchestrate robust cellular proliferation, stimulate de novo synthesis of collagen and elastin, and facilitate comprehensive extracellular matrix (ECM) remodeling. Clinically, PRP leads to significant enhancements in skin tone and texture, precise reduction of wrinkles, improved elasticity, and effective minimization of acne scars and enlarged pores. Furthermore, it accelerates post-procedure recovery, aids in repairing photodamaged skin, promotes angiogenesis (new capillary growth), re-epithelialization, and may mitigate UV-induced damage by downregulating MMP-1 and tyrosinase while upregulating tropoelastin and fibrillin.

Research

Clinical Evidence

Medium confidence
Effective range N/A
Optimal

N/A

Key findings

  1. 01 A pilot study demonstrated that topical PRP, applied twice daily for 8 weeks following electroporation, significantly improved rete peg architecture, upregulated collagen type I mRNA and protein, enhanced epidermal cellular hydration, and delivered directional improvements in radiance, luminosity, firmness, and softness within 4 to 8 weeks compared to a base serum alone.
  2. 02 A specialized refrigerated topical cosmetic formulation of PRP exhibited 90-day stability and yielded statistically significant improvements in overall facial appearance after 16 weeks of consistent application.
  3. 03 Clinical application of PRP treatments (typically 1 to 3 sessions) led to substantial enhancements across multiple facial parameters, including reduced skin pore size, improved texture, decreased wrinkle depth, fading of pigmented spots, increased collagen density, elevated hyaluronic acid levels, and enhanced protection against ultraviolet damage.

Transparency

Dusting Analysis

Not commonly dusted

The efficacy of Human Plasma, particularly as Platelet-Rich Plasma (PRP), is predicated on the presence of a biologically active concentration of growth factors. Its application is generally associated with professional preparations or specialized formulations requiring specific delivery methods, making the concept of 'dusting' at ineffective minimal percentages irrelevant.

The Formula

Formulation

Solubility
Water
Optimal pH N/A
0 7 14

Stability

Optimal stability for PRP, particularly its active growth factors like PDGF, requires refrigeration at 4 degrees Celsius, with studies indicating up to 90-day stability in specific preservative serums. A meticulously balanced buffer system is critical for maintaining pH integrity, and incorporating a film-forming agent like polyacrylate crosspolymer-6 can enhance stability at higher pH levels. It is imperative to inhibit premature degranulation of PRP until topical application to ensure maximal therapeutic efficacy.

Conflicts

  • Traditional cosmetic preservatives (known to destroy platelets)
  • Harsh or denatured alcohols (e.g., phenoxyethanol, benzyl alcohol) which can induce dehydration
  • Extreme hot temperatures (leading to plasma denaturation)

Safety

Safety Profile

CIR Status
Not reviewed
Sensitization risk Low

Neither the Cosmetic Ingredient Review (CIR) nor the Scientific Committee on Consumer Safety (SCCS) has formally reviewed Human Plasma or Platelet-Rich Plasma (PRP) as a standard mass-market cosmetic ingredient. The U.S. Food and Drug Administration (FDA) classifies PRP systems as medical devices, categorizing PRP as a '361 HCT/P' product (Human Cells, Tissues, and Cellular and Tissue-Based Products) due to its minimal manipulation and autologous nature. While its use within the 'practice of medicine' for specific aesthetic procedures may not require extensive FDA premarket approval, topical application post-procedure is generally considered 'off-label'. It is crucial to note that the FDA strictly prohibits PRP formulations containing added exogenous growth factors, hormones, or other drugs without prior Investigational New Drug (IND) approval. As PRP is autologous (derived from the patient's own blood), it is considered immunologically neutral, presenting a low risk of allergy, hypersensitivity, or foreign-body reactions.

Your Skin

Skin Compatibility

Yes Normal
Yes Dry
Yes Oily
Yes Sensitive
Irritancy Unknown
Comedogenicity Unknown

Our Assessment

Verdict

Valuable

Human Plasma, predominantly as autologous Platelet-Rich Plasma (PRP), is a biologically rich ingredient offering significant rejuvenating benefits through its potent growth factors, though its complex sourcing, precise formulation requirements, and regulatory profile necessitate specialized application.

Related

Similar Ingredients

Finding similar ingredients…